Walk-through survey of E. I. du Pont de Nemours and Company, Inc., Louisville, Kentucky.
Authors
Jones JH; Young RJ; Selevan S
Source
Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, IWS 87-10, 1975 Dec; :1-9
A walk through survey was conducted at the E.I. du Pont de Nemours and Company, Inc., Louisville, Kentucky to observe the manufacture of neoprene and discuss environmental monitoring programs for the safety of employees. Unrefined, refrigerated chloroprene (126998) monomer was brought to the facility where it was distilled as needed. Chloroprene monomer, resin, and modifier were mixed and added with a water solution in a large glass lined reactor vessel for polymerization. Modification of the remaining steps allowed production of either full conversion latex or a solid material. The company provided complete preemployment physicals, and one every 3 years for employees less than 40 years old and once every 1.5 years for those over 40. Three cases of asbestosis have been reported in pipe insulation workers. Some cases of skin cancer were documented and hair loss due to chloroprene exposure was also noted. A chloroprene monitoring program was begun in the early 1970s; corrective actions were taken to lower chloroprene concentrations. Asbestos (1332214) was no longer used on process piping but potential exposure still exists. Acrylonitrile (107131) was used as a copolymer in chloroprene production. Exposure to talc (14807966) was also possible. Freon-22 (75456) was manufactured at this location. The authors recommend that exposure to chloroprene be kept as low as possible.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.